colitis
[ col- + -itis]
Inflammation of the colon.
SEE: dysentery; gay bowel syndrome; Crohn disease.
antibiotic-associated c.Antibiotic-induced diarrhea.
SEE: pseudomembranous colitis.
ABBR: CC
Chronic watery diarrhea of unknown cause, in which the appearance of the bowel during endoscopic examination is normal. Biopsies of the bowel wall reveal thickening of the collagen layer beneath the colonic epithelium. CC is 10 times more common in women than in men and is usually diagnosed in people between 40 and 60 years of age.E. coli 0157:H7 c.An infectious, bloody diarrhea caused by Escherichia coli 0157:H7.
SEE: E. coli 0157:H7..
infectious c.Colitis caused by pathogens such as amebas, bacteria, and protozoa. It may be caused by Campylobacter, Cryptosporidium, Escherichia coli, Entamoeba histolytica, Giardia, Salmonella, or Shigella.
ABBR: LC
Chronic watery diarrhea of unknown cause, in which the endoscopic and radiological appearance of the bowel wall is normal. Biopsies of the bowel wall reveal excessive numbers of lymphocytes within the intestinal epithelium. LC is equally common in men and women and is usually diagnosed in people between 40 and 60 years of age.ABBR: MC
Either of two forms of colitis (collagenous and lymphocytic), in which people have chronic, watery diarrhea despite having normal-appearing bowels during endoscopy or radiological study.pseudomembranous c.Colitis associated with antibiotic therapy and , sometimes, with chronic debilitating illnesses in adult patients in the community. It is caused by one of two exotoxins produced by Clostridium difficile, which is part of the normal intestinal flora. Broad-spectrum antibiotics disrupt the normal balance of the intestinal flora and allow an overgrowth of strains that produce toxins. The exotoxins damage the mucosa of the colon and produce a pseudomembrane composed of inflammatory exudate. The symptoms (foul-smelling diarrhea with gross blood and mucus, abdominal cramps, fever, and leukocytosis) usually begin 4 to 10 days after the start of antibiotic therapy. The disease is treated by discontinuing previously prescribed antibiotics and beginning therapy with oral metronidazole; use of vancomycin should be limited to patients who do not respond to metronidazole. Diarrhea may reappear in approx. 20% of patients after treatment, necessitating a second course of therapy.
radiation c.Colitis due to damage of the bowel by radiation therapy. The symptoms are those of an inflamed bowel (pain, cramps, diarrhea, and rectal bleeding). Malabsorption may develop as a result of permanent injury to the mucosa.
segmental c. associated with diverticulitis
ABBR: SCAD
Focal areas of chronic inflammation in the large bowel occurring after an attack of diverticulitis. This condition may be suggested on colonoscopy by the presence of red markings in the wall of the colon (Fawaz spots).ABBR: UC
A chronic inflammatory disease of the colon characterized by continuous inflammation of the intestinal mucosa, which typically involves the anus, rectum, and distal colon, and sometimes affects the entire large intestine. It occurs most often in patients during the second or third decade of life, although a second cluster of cases occurs in patients in their sixties. The disease is associated with an increased incidence of cancer of the colon.SEE: Crohn disease; inflammatory bowel disease; Nursing Diagnoses Appendix.
In the U.S., the prevalence of UC in adults is about 200 to 240 per 100,000.
Bloody diarrhea and pain with the passage of stools are characteristic. In severe cases, patients may have more than six bloody bowel movements in a day. Iron-deficiency anemia often develops as a result.
Although the bowel is the primary symptomatic organ in UC, nearly a quarter of all patients have extraintestinal disease, including joint disease, eye disease, primary sclerosing cholangitis, and skin diseases.
Endoscopy is used to identify involved regions of the bowel and to obtain biopsies for pathological examination. Biopsy criteria for the diagnosis of UC include plasmacytosis in the lamina propria of involved bowel; elevated eosinophil counts; and distortion of the architecture of intestinal crypts. Unlike Crohn disease, bowel involvement in UC is continuous.
UC patients have an increased risk of colon cancer relative to people without the disease. Periodic colonoscopic surveillance, usually starting about 5 to 10 years after diagnosis, can be used to identify the development of dysplastic or malignant change in the bowel. The likelihood of developing colorectal cancer is greatest in individuals diagnosed early in life (in the teenage years).
Topical mesalamine is often used for ulcerative proctitis, when inflammation in the rectum occurs without more widespread or systemic disease. Disease that involves the left side of the colon is typically treated with topical (rectal) aminosalicylates, e.g. sulfasalazine, plus oral mesalamine. Extensive disease that involves the entire colon should be treated with oral mesalamine combined with topical mesalamine, and with systemic corticosteroids if the bleeding, stool frequency, and pain do not resolve promptly. Severe disease with systemic symptoms typically requires hospitalization, intravenous steroids, cyclosporine or tacrolimus, infliximab, and consultations with specialists (gastroenterologist and surgeons). Toxic megacolon or intestinal perforation require urgent surgical consultation.
Nine of ten patients with UC have intermittent disease flares followed by periods of remission. These individuals have a clinically milder disease, often with limited (rectal or left-sided) disease only. The remainder may have disease that is difficult to manage with medications alone, and therefore may require surgical removal of the entire large bowel.
SEE: panproctocolectomy..
The patient is prepared for diagnostic studies (sigmoidoscopy, colonoscopy, barium enema, CT scan) and is told that the procedure can be uncomfortable and fatiguing. He or she is taught to understand and participate in treatment goals: controlling inflammation, maintaining or restoring fluid and electrolyte balance, receiving adequate nutrition and replacing nutritional losses, and preventing complications. The nurse or dietitian teaches the patient about dietary intake, which should be high-caloric, nonspicy, caffeine-free, and low in high-residue foods and milk products. Actual dietary and caloric intake must be documented. If the patient is unable to take fluids by mouth, IV fluid and electrolyte replacement or parenteral nutrition are instituted as prescribed. Fluid intake and output are monitored, particularly for frequency, volume, and characteristics of diarrhea. The patient is monitored for dehydration and electrolyte imbalances, particularly hypokalemia, hypernatremia, and anemia.
Prescribed drug therapy is administered, and the patient is evaluated for desired and adverse effects and is taught about the particulars of his or her regimen, which usually includes sulfasalazine (5-ASA), prescribed for its antibiotic and anti-inflammatory effects. Studies have shown that, in high-risk patients, 5-ASA given both orally and by enema appears to sustain remission better than oral therapy alone. Since 5-ASA interferes with folate metabolism, use of a folate supplement is encouraged. Corticosteroids such as prednisone often are prescribed to reduce inflammation. The patient is taught that once clinical remission is achieved, steroid therapy can be tapered gradually and discontinued, but should never be summarily stopped. If the patient requires prolonged steroid therapy, he or she must report gastric irritation, edema, personality changes, moon face, and hirsutism. Corticosteroids given chronically may produce many serious side effects, including bone loss, diabetes mellitus, and cataracts. Antispasmodic and antidiarrheal agents (tincture of belladonna, diphenoxylate, loperamide) are used rarely and with great caution because they can precipitate colonic dilation (toxic megacolon). Measures to prevent perianal skin breakdown are reviewed, e.g., cleaning the rectal area thoroughly but gently following each bowel movement, applying a moisture barrier such as petroleum jelly, and changing position frequently.
While surgery is considered only for patients who do not respond to pharmacological therapies, several surgical procedures are available to attempt to preserve rectal evacuation. Bowel surgeries require a special antibiotic preparation, and postoperative care includes all general patient care concerns. In addition, a temporary nasogastric tube is usually inserted, and a diet is gradually advanced after removal of the tube. The patient may have a permanent or temporary stoma or a pouch ileostomy and may require ongoing teaching and support from a stomal therapist and support groups for help and management.
